The overall objective of this study is to test a personalized mHealth intervention designed to increase physical activity and improve medication adherence in subjects with heart failure and diabetes mellitus. The study will leverage consumer technology as both an intervention and as a tool for data collection.
This is a multi-center randomized controlled study in eligible subjects with heart failure and diabetes mellitus. Step counts, self-reported quality of life, medication adherence, blood samples and relevant clinical measures will be collected from all study subjects. The mobile health (mHealth) intervention will combine personalized text messages to encourage physical activity and a medication adherence teaching tool. A total of approximately 200 eligible subjects will be randomized in in a 1:1 ratio to either mHealth intervention + usual care/data collection or the control group (usual care/data collection only). The study duration is 6 months for all subjects; those in the intervention group will receive the mHealth intervention during the initial 3 months followed by 3 months of data collection only. The underlying hypotheses is that the proposed mHealth intervention can favorably impact specific health behaviors (physical activity and medication adherence) and physiologic measures of disease status for both heart failure and diabetes. Additional hypotheses to be tested will assess the persistence of behavioral changes (daily physical activity and medication adherence) and physiologic measures (NT-proBNP, HbA1c) beyond the 3-month time point of the active mHealth intervention (i.e. through 6 months).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
187
Personalized step count feedback and medication teaching tool.
Stanford University School of Medicine
Stanford, California, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
NewYork-Presbyterian Brooklyn Methodist Hospital
Brooklyn, New York, United States
Duke University Medical Center
Durham, North Carolina, United States
Change in mean weekly step count
Increased activity
Time frame: from baseline to 3 months
Change in medication adherence score
Improved medication adherence
Time frame: from baseline to 3 and 6 months
Change in fill and refill performance rate
Change in fill and refill performance rate
Time frame: from baseline to 3 and 6 months
Change in mean weekly step count
Increased activity
Time frame: from 3 to 6 months
Change in NT-proBNP levels
biomarkers
Time frame: from baseline to 3 to 6 months
Change in HbA1C levels
biomarkers
Time frame: from baseline to 3 to 6 months
Change in Kansas City Cardiomyopathy Questionnaire (KCCQ) score
QOL
Time frame: from baseline to 3 to 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Inova Health System
Fairfax, Virginia, United States